Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1979 Jun;39(6):700–704. doi: 10.1038/bjc.1979.123

Cancer of the prostate: early diagnosis by zinc and hormone analysis?

F K Habib, M K Mason, P H Smith, S R Stitch
PMCID: PMC2009984  PMID: 87214

Abstract

Zinc, testosterone and dihydrotestosterone concentrations have been measured in normal prostatic tissue and in specimens obtained from untreated patients with benign prostatic hyperplasia (BPH) and carcinoma of the prostate (CaP). The metal--androgen relationship was examined and related to the pathological condition of the patients. The evidence suggests that discriminant analysis combining the hormonal data into a single variable is a reliable test for distinguishing between BPH and CaP patients. We have observed that the high Zn values found in BPH specimens were always associated with a DTH:T ratio greater than 1. Androgen tissue ratios less than 1 were characteristic of all CaP specimens, and these were usually preceded by a reduction in prostatic Zn concentration. Since these patterns, particularly those associated with neoplasia, precede the clinical manifestations, they may be used as an index for predicting the onset of carcinoma in the prostate gland. They may also be of value in monitoring the progress of the disease.

Full text

PDF
700

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dawson J. B., Walker B. E. Direct determination of zinc in whole blood, plasma and urine by atomic absorption spectroscopy. Clin Chim Acta. 1969 Dec;26(3):465–475. doi: 10.1016/0009-8981(69)90075-8. [DOI] [PubMed] [Google Scholar]
  2. FOULDS L. The natural history of cancer. J Chronic Dis. 1958 Jul;8(1):2–37. doi: 10.1016/0021-9681(58)90039-0. [DOI] [PubMed] [Google Scholar]
  3. Geller J., Albert J., Loza D., Geller S., Stoeltzing W., de la Vega D. DHT concentrations in human prostate cancer tissue. J Clin Endocrinol Metab. 1978 Mar;46(3):440–444. doi: 10.1210/jcem-46-3-440. [DOI] [PubMed] [Google Scholar]
  4. Györkey F., Min K. W., Huff J. A., Györkey P. Zinc and magnesium in human prostate gland: normal, hyperplastic, and neoplastic. Cancer Res. 1967 Aug;27(8):1348–1353. [PubMed] [Google Scholar]
  5. Habib F. K., Hammond G. L., Lee I. R., Dawson J. B., Mason M. K., Smith P. H., Stitch S. R. Metal-androgen interrelationships in carcinoma and hyperplasia of the human prostate. J Endocrinol. 1976 Oct;71(1):133–141. doi: 10.1677/joe.0.0710133. [DOI] [PubMed] [Google Scholar]
  6. Habib F. K., Lee I. R., Stitch S. R., Smith P. H. Androgen levels in the plasma and prostatic tissues of patients with benign hypertrophy and carcinoma of the prostate. J Endocrinol. 1976 Oct;71(1):99–107. doi: 10.1677/joe.0.0710099. [DOI] [PubMed] [Google Scholar]
  7. Habib F. K. Zinc and the steroid endocrinology of the human prostate. J Steroid Biochem. 1978 May;9(5):403–407. doi: 10.1016/0022-4731(78)90608-8. [DOI] [PubMed] [Google Scholar]
  8. SCHRODT G. R., HALL T., WHITMORE W. F., Jr THE CONCENTRATION OF ZINC IN DISEASED HUMAN PROSTATE GLANDS. Cancer. 1964 Dec;17:1555–1566. doi: 10.1002/1097-0142(196412)17:12<1555::aid-cncr2820171207>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES